{"nct_id":"NCT06247995","title":"A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2024-08-14","start_date_type":"ACTUAL","primary_completion_date":"2031-09-09","primary_completion_date_type":"ESTIMATED","completion_date":"2031-09-09","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["NVS"]}